Christoph U. Correll, MD

Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Hempstead, New York; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; German Center for Mental Health (DZPG), partner site Berlin, Berlin, Germany

ASCP Corner

Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic Disorders

March 29, 2017

This month's ASCP Corner discusses the significant problem of untreated psychosis. The authors review the factors that contribute to a longer time to treatment, the impact of untreated psychosis,...

Christoph U. Correll, Jose M. Rubio

Article

Mood Disorders and Antipsychotic Treatment in Youth

March 29, 2017

The increasing overlap of mood disorders and antipsychotic use in youth is a growing area of concern. This meta-analysis examined the current findings on the frequency of mood disorders...

Mark Olfson, Christoph U. Correll, Tobias Gerhard, et al

Meta-Analysis

Tardive Dyskinesia Prevalence

March 29, 2017

With the advent of second-generation antipsychotics, hopes were high that tardive dyskinesia would all but disappear as a side effect. However, it persists. In this meta-analysis, Carbon et al...

John M. Kane, Christoph U. Correll, Maren Carbon, et al

Meta-Analysis

Neurocognition in Clinical High Risk for Psychosis

January 25, 2017

Is your patient showing signs of what might be an early phase of prepsychotic illness? Read this meta-analysis for information on how specific cognitive impairments hold promise for predicting...

John M. Kane, Barbara A. Cornblatt, Christoph U. Correll, et al

Original Research

Baseline Metabolic Status in Early-Onset Psychosis

January 17, 2017

The shorter life expectancy in patients with psychotic disorders is largely due to an increased risk of obesity, diabetes, and cardiovascular disease. This comparison of youths with first-episode psychosis...

Christoph U. Correll, Anders Fink-Jensen, Karsten G. Jensen, et al

Article

Low Hemoglobin and Depression

December 28, 2016

Although studies have suggested an association between anemia and depression in the elderly, prospective research has yet to clarify of the directionality of that association. Read this article to...

Christoph U. Correll, Caterina Trevisan, Nicola Veronese, et al

Supplement Article

Injectable Antipsychotics in Schizophrenia

September 30, 2016

Read the recommendations of experts on the use of long-acting injectable antipsychotic medications in patients with schizophrenia.

Leslie Citrome, Mark Olfson, John M. Kane, et al

Review Article

Benign Ethnic Neutropenia & Clozapine Use

July 27, 2016

Read a full review examining whether Benign Ethnic Neutropenia (BEN) should prevent treatment with clozapine.

John M. Kane, Christoph U. Correll, Peter Manu, et al

Meta-Analysis

Topiramate-Antipsychotic Cotreatment

June 22, 2016

Topiramate is known to cause weight loss, but it's also known to cause adverse psychiatric side effects. So how would topiramate affect patients already taking antipsychotics? Read this meta-analysis...

Dan Cohen, Marc De Hert, Christoph U. Correll, et al

Letter to the Editor

Dr Nielsen and Colleagues Reply

December 23, 2015

John M. Kane, Christoph U. Correll, Peter Manu, et al

Meta-Analysis

Comparison of ODD vs Healthy Controls

December 23, 2015

Read the full article showing results from use of Oxidative Stress and Antioxidant Parameters in Patients with MDD compared to Healthy Controls.

Christoph U. Correll, Manuel Gurpegui, Miriam Gerstenberg, et al

Article

Frequency and Correlates of DSM-5 Attenuated Psychosis Syndrome in a Sample of Adolescent Inpatients With Nonpsychotic Psychiatric Disorders

November 25, 2015

John M. Kane, Barbara A. Cornblatt, Christoph U. Correll, et al

« 1 … 4 5 6 7 8 … 11 »